Xenetic Biosciences Inc. (XBIO)
NASDAQ · Healthcare
Xenetic Biosciences Inc. Shareholder Equity 2012–2025
Xenetic Biosciences Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Xenetic Biosciences Inc. shareholder equity as of December 31, 2025: 7.4M, a 23.12% increase year-over-year.
- Xenetic Biosciences Inc. shareholder equity for 2025 were 7.4M, a 23.12% increase from 2024.
- Xenetic Biosciences Inc. shareholder equity for 2024 were 6.0M, a 38.67% decrease from 2023.
- Xenetic Biosciences Inc. shareholder equity for 2023 were 9.8M, a 28.22% decrease from 2022.
- Xenetic Biosciences Inc. shareholder equity for 2022 were 13.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Xenetic Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $6 |
| 2023 | $10 |
| 2022 | $14 |
| 2021 | $18 |
| 2020 | $12 |
| 2019 | $17 |
| 2018 | $10 |
| 2017 | $14 |
| 2016 | $16 |
| 2015 | $7 |
| 2014 | $10 |
| 2013 | $13 |
| 2012 | $21 |
Xenetic Biosciences Inc. Shareholder Equity — FAQ
Xenetic Biosciences Inc. (XBIO) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XBIO's shareholder equity history?
The chart and table above show Xenetic Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.